| Gene therapy: evidence, value and affordability in the US health care system |
13 |
| A 90-day episode-of-care cost analysis of robotic-arm assisted total knee arthroplasty |
11 |
| Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries |
10 |
| Real-world evidence for coverage decisions: opportunities and challenges |
9 |
| Persistence and adherence of biologics in US patients with psoriatic arthritis: analyses from a claims database |
9 |
| Evaluation of antihypertensive adherence and its determinants at primary healthcare facilities in rural South Africa |
8 |
| Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics |
8 |
| Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database |
7 |
| Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasis |
7 |
| Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysis |
6 |
| Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review |
6 |
| Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib |
6 |
| Variation in prostate surgery costs and outcomes in the USA: robot-assisted versus open radical prostatectomy |
6 |
| Effect of frailty on resource use and cost for Medicare patients |
6 |
| Second-line rituximab-bendamustine versus rituximab-gemcitabine-oxaliplatin in diffuse large B-cell lymphoma in the real world |
6 |
| A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions |
6 |
| Medicaid spending burden among beneficiaries with treatment-resistant depression |
5 |
| Indicator of access to medicines in relation to the multiple dimensions of access |
5 |
| Cost-effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA |
5 |
| Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry |
5 |
| Incidence and costs of cardiac device infections: retrospective analysis using German health claims data |
5 |
| Comparing efficacy of enteral nutrition plus ranitidine and enteral nutrition alone as stress ulcer prophylaxis |
5 |
| Transitioning from learning healthcare systems to learning health care communities |
5 |
| Impact of selective serotonin reuptake inhibitors in the veteran population: 10-year risk outcomes |
4 |
| Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study |
4 |
| Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients |
4 |
| An indirect comparison of ustekinumab and vedolizumab in the therapy of TNF-failure Crohn's disease patients |
4 |
| Experience with developing antibiotic stewardship programs in Serbia: potential model for other Balkan countries? |
4 |
| Ticagrelor versus clopidogrel in East-Asian patients with acute coronary syndromes: a meta-analysis of randomized trials |
4 |
| Evaluation of a mobile social networking application for improving diabetes Type 2 knowledge: an intervention study using WhatsApp |
4 |
| Treatment patterns and outcomes for patients with unresectable stage III and metastatic melanoma in the USA |
4 |
| Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis |
4 |
| Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia |
4 |
| Cost-effectiveness of overactive bladder treatments: from the US payer perspective |
4 |
| Comparative effectiveness of a bilayered living cellular construct and an acellular fetal bovine collagen dressing in the treatment of venous leg ulcers |
3 |
| Qualitative interviews to identify burden of illness, impacts and costs associated with surgical site infections |
3 |
| Evolution of functional class,biochemical and echocardiographic parameters and clinical outcomes after sacubitril/valsartan initiation in daily practice |
3 |
| Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study |
3 |
| Indirect comparison of nivolumab +/- ipilimumab (CheckMate 032) versus other treatments for recurrent small-cell lung cancer |
3 |
| Economic evaluation of trifluridine and tipiracil hydrochloride in the treatment of metastatic colorectal cancer in Greece |
3 |
| Comparing outcomes between barbed and conventional sutures in patients undergoing knee or hip arthroplasty |
3 |
| Comparison of therapies in lumbar degenerative disc disease: a network meta-analysis of randomized controlled trials |
3 |
| Gastrointestinal complications in patients treated with ipilimumab and nivolumab combination therapy or monotherapy |
3 |
| Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits |
3 |
| Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder |
3 |
| Agreement between manual and automatic analyses of home sleep examinations in pediatric obstructive sleep apnea |
3 |
| Patients' early engagement in research proposal development (PEER-PD): patients guiding the proposal writing |
3 |
| Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA |
3 |
| Sickle cell disease and readmissions rates after lower extremity arthroplasty: a multistate analysis 2007-2014 |
2 |
| Social determinants of health and their impact on postcolectomy surgery readmissions: a multistate analysis, 2009-2014 |
2 |
